APOB and thyroid cancer: Finally, given the relatively small number of studies on LDL-C/HDL-C ratio [24], ApoA-I [24], ApoB [24,25], and ApoB/ApoA-I ratio [24], more research is needed to validate the null findings of the present study on these biomarkers in thyroid cancer.